BioScrip execs will continue at combined company
By HME News Staff
Updated Thu June 13, 2019
DENVER - Key members of BioScrip's leadership team will continue in executive roles with the combined company following the close of its pending merger with Option Care Enterprises. Dan Greenleaf, president and CEO of BioScrip, will become special advisor to the newly combined company's board chairman, Harry Kraemer, and CEO John Rademacher. Greenleaf will provide strategic and operational counsel to ensure a smooth transition, optimize the integration of both companies and drive long-term opportunities. In addition, Harriet Booker will continue as COO, Rich Denness will become chief strategy officer, John McMahon will become senior vice president of corporate finance, Bob Roose will continue as senior vice president of procurement and Arcot Prakash will become vice president of information technology.
Comments